Investigators searched for predictors of insensitivity to neoadjuvant cisplatin-based chemotherapy among patients with muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback